Previous Close | 16.97 |
Open | 16.88 |
Bid | 16.85 x N/A |
Ask | 16.91 x N/A |
Day's Range | 16.75 - 16.92 |
52 Week Range | 6.10 - 16.92 |
Volume | |
Avg. Volume | 3,009 |
Market Cap | 929.723M |
Beta (5Y Monthly) | 0.92 |
PE Ratio (TTM) | 5.89 |
EPS (TTM) | 2.86 |
Earnings Date | May 09, 2024 - May 13, 2024 |
Forward Dividend & Yield | 0.46 (2.71%) |
Ex-Dividend Date | Mar 27, 2024 |
1y Target Est | 21.75 |
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces that it will hold a conference call to discuss its first quarter 2024 financial results on Tuesday, May 7, 2024, at 8:00 a.m. ET. The Trust will report its financial results on Monday, May 6, 2024, after market close.
DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces the refinancing of its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 in-the-money warrants (collectively, the "Existing Securities").
DRI Healthcare Trust (TSX: DHT.UN) ( TSX: DHT.U) ("DRI" or the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, today announced that the Trust will participate in the following investor conferences in April and May: